Armando Anido, Chairman & Chief Executive Officer at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 15,000 shares at $5.96 ($89K) on 2018-08-06, disclosed to the SEC on 2018-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZYNE | SELL | 2022-07-20 | $13K | — | Filing → |
| SCYX | BUY | 2020-12-23 | $31K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $99K | — | Filing → |